BioSpace News Archive

Press Releases

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

October 29, 2024
·
8 min read
Press Releases

Castle Biosciences Presents Award-Winning Abstract at ACG 2024 Demonstrating Ability of Its TissueCypher® Test to Significantly Reduce Healthcare Costs Associated with the Management of Barrett’s Esophagus Patients

October 29, 2024
·
5 min read
Press Releases

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

October 29, 2024
·
1 min read
Press Releases

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease

October 29, 2024
·
15 min read
Press Releases

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

October 29, 2024
·
6 min read
Press Releases

VIVUS Shares Significant Regulatory Update on QSYMIA®

October 29, 2024
·
8 min read
Press Releases

Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients

October 29, 2024
·
4 min read
Press Releases

BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

October 29, 2024
·
4 min read
Press Releases

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years

October 29, 2024
·
5 min read
Press Releases

Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months

October 29, 2024
·
5 min read